Delivery Order SPE2DB22D1002-SPE2DB25FKTT7

Award Date 11/4/24
Potential Completion Date 11/5/24
Potential Value $5.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $2,537.26 and an ultimate completion date of April 1, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the...
This federal contract award is for the delivery of NURTEC ODT 75 MG TABLET 8S to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $8,854.78, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is December 4, 2024. The contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $18,060.64 firm-fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a...
This federal contract award is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a ceiling value of $8,607.84. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of November 6, 2024. This contract is not designated as a set-aside. Amerisourcebergen...
This federal contract award is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $9,503.14 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on April 22, 2024, with a completion date of April 23, 2024. The award is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $10,060.43 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999. This larger IDC serves as a primary contracting vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $36,269.36 and a completion date of January 28, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with...
This federal contract award is for the delivery of NURTEC ODT 75 MG TABLET 8S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on January 10, 2025 with a completion date of January 13, 2025. The contract has a ceiling value of $8,664.07 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This federal contract award is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $17,087.62 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of June 6, 2024. The contract is not designated as a set-aside and was awarded as...
This federal contract award is for the delivery of NURTEC ODT 75 MG TABLET 8S, a prescription medication, to the Defense Logistics Agency (DLA). The $6,222.73 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of June 4, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB25FKTT7
    Delivery Order

This federal contract award is for the delivery of NURTEC ODT 75 MG TABLET 8S to the Defense Logistics Agency (DLA), a defense agency. The $5,101.00 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/20/25, 2:33 PM